Navigation Links
Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
Date:2/25/2009

Angiomax Will Remain the NSTEMI Market Share Leader Through 2017, According to a New Report from Decision Resources

WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy's effect on incidence of mortality at 30 days is the attribute that most influences surveyed cardiologists' prescribing decisions in non-ST elevation myocardial infarction (NSTEMI). Data and the opinions of interviewed thought leaders indicate that current and emerging drugs, including Eli Lilly/Daiichi Sankyo's Efient, have no advantage in this attribute over The Medicines Company's Angiomax, the market sales leading agent.

The new report entitled NSTEMI: Finding the Balance between Efficacy and Safety finds that a drug that reduces mortality more than Angiomax at 30 days with significantly lower rates of bleeding would earn a 50 percent patient share in the United States and a 60 percent patient share in Europe, according to surveyed U.S. and European cardiologists. Angiomax, which was Decision Resources' proprietary clinical gold standard in 2008 for NSTEMI, will remain the clinical gold standard therapy and the market share leader through 2017, due to its efficacy and safety

The report finds that although some therapies in development for NSTEMI hold promise, most have either efficacy or safety and tolerability features that surveyed cardiologists rated inferior when compared with Angiomax. New agents in the market include Efient, which was approved by the European Medicines Agency in February 2009 for treatment of NSTEMI in the European Union.

"Angiomax has the most robust clinical data of drugs in its class for its use in NSTEMI and benefits from an immediate onset of action, which has driven physician usage and has enabled it to dominate the NSTEMI market," said Decision Resources Analyst
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
2. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
3. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
4. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
7. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
8. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
9. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) ... and turnkey support services for the lawfully organized ... processed and approved the Company,s name and symbol ... Corporation will be known as Chuma Holdings, Inc. ... through a merger with the Company,s wholly-owned subsidiary, ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- SAM Medical Products Implements Voluntary ... SAM Junctional Tourniquet.  Photo - ... Products announced today that it has begun notifying ... potential issue with a clip used to secure ... of the SAM Junctional Tourniquet (SJT).  The company ...
(Date:8/29/2014)...   Mast Therapeutics, Inc. (NYSE MKT: ... Santosh Vetticaden, Chief Medical Officer and Senior Vice ... reasons, in mid-September.  Edwin L. Parsley , ... which Mast acquired earlier this year, will assume ... Chief Medical Officer.  Dr. Parsley previously was with ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Subtypes of AML, Including Those with Poorest Prognoses , ... Eisai Corporation of North America today announced data from a ... (decitabine for injection) in acute myeloid leukemia (AML), the most ... with AML, who often have limited options due to comorbidities ...
... and AMSTERDAM, December 8 ,Agendia, a world leader ... and the Netherlands Cancer Institute researchers will present,data ... Breast Cancer Symposium,(SABCS) and Agendia will support, with ... Cancer Therapy symposium. The San Antonio,Breast Cancer Symposium, ...
Cached Medicine Technology:Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 2Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 3Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 4Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 2Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 3Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 4
(Date:9/1/2014)... (PRWEB) September 01, 2014 "Women struggle ... These hormonal daily changes begin as early as 15, ... their lives negotiating the ups and downs of hormone ... thin or even healthy sizes seems to rage against ... As a woman in her 40's begin to face ...
(Date:9/1/2014)... Thompson HealthDay Reporter FRIDAY, ... previously given to two American aid workers successfully cured a ... tests, researchers report. The drug, ZMapp, prompted recovery in ... get the medication until five days after infection. ZMapp ... days or even hours away from death, said study senior ...
(Date:9/1/2014)... Monday 1 September 2014: Permanent atrial fibrillation (AF) ... according to research in more than 6 000 patients ... from Belgium. The findings suggest that a simple clinical ... to better estimate stroke risk. , Ischaemic stroke is ... for over a million deaths and many more disabled ...
(Date:9/1/2014)... 2014 The National Association of Hispanic ... Dawn Bazarko, DNP, MPH, RN, and Adriana Perez, PhD, ... Academy of Nursing. They will be inducted with Immediate ... whose induction we reported last May. , Our three ... the 2014 American Academy of Nursing Policy Conference in ...
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... store, retrieve, organize and analyze biological and genetic ... of the activity of developing software tools to ... not to be confused with biological computation. While ... better understanding of biology can its related concepts, ...
Breaking Medicine News(10 mins):Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4
... drug use, delivery made a measurable impact in Planned ... Two changes to the way Planned Parenthood clinics perform ... the rate of serious infections, a new report says. ... the area between the gum and the cheek (buccal ...
... ... essential for embryonic stem cells to maintain their all-purpose, pluripotent state. Exploiting the finding ... a strategy to efficiently reprogram mature cells back into the pluripotent state, an elusive step ... , ...
... In a new letter to the three key leaders shaping ... Ways and Means Chairman Charles Rangel (D-NY), Energy and Commerce ... Miller (D-CA) - the Coalition to Protect Senior Care (CPSC) ... could harm seniors, care, cut thousands of key frontline care ...
... more articulate essays were protected from symptoms , WEDNESDAY, July ... early adulthood were less likely to have Alzheimer,s disease later ... that are hallmarks of the disease. , Also, ... neurons, according to a study appearing in the July 9 ...
... tell you that raising a preschooler is no easy task. ... up a child with autism or a developmental delay. ... about their experiences and found that moms of children with ... than mothers of children with developmental delay. Children,s problem ...
... , CHICAGO, July 8 The ... of its 75 city tour, including the top 10,Hispanic cities, ... benefits. The tour recently cruised through Chicago hosting free,events to ... drink well,with nature,s wellness drink: milk. , ...
Cached Medicine News:Health News:Changes Reduced Infections From Medical Abortion 2Health News:Changes Reduced Infections From Medical Abortion 3Health News:Stem Cells' "Suspended" State Preserved by Key Step, Scientists Report 2Health News:Stem Cells' "Suspended" State Preserved by Key Step, Scientists Report 3Health News:Stem Cells' "Suspended" State Preserved by Key Step, Scientists Report 4Health News:New Letter to Rangel, Waxman, Miller from National Seniors Coalition Outlines Concerns With House Tri-Committee Health Reform Bill 2Health News:New Letter to Rangel, Waxman, Miller from National Seniors Coalition Outlines Concerns With House Tri-Committee Health Reform Bill 3Health News:New Letter to Rangel, Waxman, Miller from National Seniors Coalition Outlines Concerns With House Tri-Committee Health Reform Bill 4Health News:Greater Language Skills in 20s May Guard Against Alzheimer's 2Health News:Greater Language Skills in 20s May Guard Against Alzheimer's 3Health News:Mothers of children with autism have higher parental stress, psychological distress 2Health News:Mothers of children with autism have higher parental stress, psychological distress 3Health News:The Hispanic got milk? Campaign Visits Chicago from July 2 - July 10 2
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
... The Guidant INSIGNIA ... sophisticated patient-specific, easy-to-use features ... and enhanced patient safety. ... are programmed using the ...
... model 1688 and model 1488 active-fixation leads ... leads, offering the unsurpassed handling advantages, performance, ... line of active-fixation leads. Implantable with a ... of the Tendril SDX lead is designed ...
... FlashLink Wireless is a stand-alone real-time ... provides for user defined set up, ... for temperature and humidity. It offers ... as hospitals, blood banks, laboratories, refrigerators, ...
Medicine Products: